ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633016 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633016; 2) Community: the network communities that were significantly associated with the response to NSC 633016; 3) Molecule: the relationships between components within communities and NSC 633016; 4) MDR: the compounds that were significantly associated with the NSC 633016.

NSC Compound Enrichment Correlation
NSC 710587 Null 0.0314734733353265 0.47228404
NSC 724855 N,N,N,N-Tetraethyl-thieno[3,4-f][1,2,3,4,5]pentathiepine-6 ,8-diamine 0.0314734733353265 0.26098532
NSC 727049 11-(6'-Aminohexylidene]-5,6-dihydro-5-keto-2,3-dimethoxy-6-m ethyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline 0.0314734733353265 0.31241248
NSC 748909 Chonemorphine 0.0314734733353265 0.18249426
NSC 753193 N-(2-(4-acetylpiperazin-1-yl)ethyl)-3-(3-chloro-5-hydroxyphenyl)-4-(pyridin-4-yl)-1H-pyrazole-1-carboxamide 0.0314734733353265 0.043216342
NSC 758662 Lovastatin [USAN] 0.0314734733353265 -0.10412207
NSC 140873 2-Amino-N-(4-chloro-2-(1H-pyrrole-2-carbonyl)phenyl)acetamide 0.0314734733353267 0.45515831
NSC 146268 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- 0.0314734733353267 0.36086041
NSC 201459 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- 0.0314734733353267 0.22447818
NSC 248040 Null 0.0314734733353267 0.1625056
Total:114  Current:90    [First] [Prev] [Next] [Last]